Characterization of Sno expression in malignant melanoma

被引:1
作者
Poser, I
Rothhammer, T
Dooley, S
Weiskirchen, R
Bosserhoff, AK
机构
[1] Univ Regensburg, Inst Pathol, Sch Med, D-93053 Regensburg, Germany
[2] Univ Heidelberg, Univ Hosp Mannheim, Dept Med 2, Mannheim, Germany
[3] Rhein Westfal TH Aachen, Inst Clin Chem, D-52074 Aachen, Germany
关键词
Sno; melanoma; transforming growth factor;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Normal cells are controlled by several exocrine factors, whereas tumor cells often lose control by antiproliferative stimuli. It is known that melanoma cells produce transforming growth factor (TGF) beta 1, 2 and 3, but do not respond with growth inhibition. Recently, the Smad inhibitor Ski was found to play a role in this process. We originally analyzed Ski expression in nine melanoma cell lines, however, only one cell line (SK Mel 28) was positive. As all nine cell lines were unresponsive to TGF-beta, we continued to search for the responsible mechanism. Sequencing of the TGF-beta-receptor II, known to be mutated in other kinds of cancer, did not reveal any mutation. A family member of Ski, the proto-oncouene Sno was strongly expressed in all melanoma cell lines on RNA and protein level, but not in melanocytes. To confirm functional relevance of this observation, we used stable antisense Sno transfection for the generation of cell clones with reduced Sno expression. These cell clones displayed reduced cell proliferation, indicating participation of Sno in the escape of melanoma cells from TGF-beta dependent growth control. Searching for TGF-beta target genes that are under control of Sno interference, Id I but not antiproliferative genes p2l, p15, p57 and p27 was identified in the cell clones after antisense Sno expression. In summary, constitutive Sno expression was identified as an important mechanism to shut off antiproliferative TGF-beta signaling in malignant melanoma.
引用
收藏
页码:1411 / 1417
页数:7
相关论文
共 26 条
[1]   Signal transduction by the TGF-β superfamily [J].
Attisano, L ;
Wrana, JL .
SCIENCE, 2002, 296 (5573) :1646-1647
[2]   Characterization of methylthioadenosin, phosphorylase (MTAP) expression in malignant melanoma [J].
Behrmann, I ;
Wallner, S ;
Komyod, W ;
Heinrich, PC ;
Schuierer, M ;
Buettner, R ;
Bosserhoff, AK .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (02) :683-690
[3]   Transforming growth factor β receptor type II inactivation promotes the establishment and progression of colon cancer [J].
Biswas, S ;
Chytil, A ;
Washington, K ;
Romero-Gallo, J ;
Gorska, AE ;
Wirth, PS ;
Gautam, S ;
Moses, HL ;
Grady, WM .
CANCER RESEARCH, 2004, 64 (14) :4687-4692
[4]  
Colmenares C, 1990, Semin Cancer Biol, V1, P383
[5]   Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene [J].
Dennler, S ;
Itoh, S ;
Vivien, D ;
ten Dijke, P ;
Huet, S ;
Gauthier, JM .
EMBO JOURNAL, 1998, 17 (11) :3091-3100
[6]   Smads "freeze" when they ski [J].
Frederick, JP ;
Wang, XF .
STRUCTURE, 2002, 10 (12) :1607-1611
[7]   The transforming activity of ski and SnoN is dependent on their ability to repress the activity of Smad proteins [J].
He, J ;
Tegen, SB ;
Krawitz, AR ;
Martin, GS ;
Luo, KX .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (33) :30540-30547
[8]   In vitro modulation of human melanoma cell invasion and proliferation by all-trans-retinoic acid [J].
Jacob, K ;
Wach, F ;
Holzapfel, U ;
Hein, R ;
Lengyel, E ;
Buettner, R ;
Bosserhoff, AK .
MELANOMA RESEARCH, 1998, 8 (03) :211-219
[9]  
KRASAGAKIS K, 1994, ANTICANCER RES, V14, P2565
[10]  
Lücke CD, 2001, CANCER RES, V61, P482